Risek IV™
Therapeutic Segment:
Anti-Ulcerant, Gastric acid suppressant
Generic Name:
Omeprazole sodium
Indication
Injectable
- 40MG
For patients who are unable to take oral therapy for the short-term (upto 5 days) treatment of:
- Gastro-oesophageal reflux disease.
- Peptic ulcer disease.
- Treatment and prophylaxis of NSAID-associated ulceration.
- Duodenal ulcer.
- Zollinger-Ellison syndrome.
- Prophylaxis of acid aspiration.